Browse Category

Stock Market News 22 January 2026

Micron stock pops in premarket as new Wall Street call lands amid a memory-price squeeze

Micron stock pops in premarket as new Wall Street call lands amid a memory-price squeeze

Micron shares rose 2.2% to $397.75 premarket Thursday after William Blair upgraded the stock to “Outperform,” following a 6.6% surge Wednesday. Memory-chip prices are spiking amid AI demand, with some products up 1,000%, raising concerns that higher costs could curb PC and smartphone shipments. Micron plans to buy Powerchip’s P5 fab in Taiwan for $1.8 billion, aiming to boost DRAM output by late 2027.
Lithium price jumps again as China spot hits 164,500 yuan; Albemarle in focus before U.S. open

Lithium price jumps again as China spot hits 164,500 yuan; Albemarle in focus before U.S. open

China’s battery-grade lithium carbonate price rose 3.8% to 164,500 yuan per ton on Thursday, extending its rebound. The Guangzhou Futures Exchange widened daily trading limits after repeated volatility. Albemarle shares gained 4.3% in U.S. trading Wednesday, while lithium ETF prices also climbed. Beijing will cut battery export VAT rebates from April, prompting expectations of increased near-term demand.
GE Aerospace earnings beat: 2026 profit forecast tops estimates as airlines keep engines in the shop

GE Aerospace earnings beat: 2026 profit forecast tops estimates as airlines keep engines in the shop

GE Aerospace forecast 2026 adjusted EPS of $7.10 to $7.40, above Wall Street estimates, citing strong demand for parts and maintenance as airlines keep older planes flying. Fourth-quarter adjusted EPS rose to $1.57, with revenue up 20% to $11.9 billion. Shares jumped nearly 4% premarket. GE reported a $190 billion backlog and record LEAP engine deliveries.
AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

Intel jumped 11.7% to $54.25 Wednesday, leading gains among AI chipmakers ahead of its quarterly report; Nvidia rose 3%, AMD 7.6%, and Micron 6.6%. Compal warned memory costs could reach up to 40% of PC component prices due to surging demand. The U.S. House advanced a bill to tighten AI chip exports, targeting Nvidia’s Blackwell chips. The S&P 500 rose 1.16% after Trump’s Greenland deal and tariff pause.
Dow Jones futures edge higher after tariff U-turn; GDP and PCE inflation data ahead

Dow Jones futures edge higher after tariff U-turn; GDP and PCE inflation data ahead

Dow Jones futures rose 61 points premarket after the index jumped 588.64 points Wednesday, following President Trump’s decision to halt planned tariffs tied to a Greenland deal. Investors await key GDP and jobless claims data at 8:30 a.m. ET, with Procter & Gamble earnings due before the bell. Markets remain sensitive to tariff headlines and political developments in Washington.
FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

The FTSE 100 rose 0.7% to 10,212.91 by 1104 GMT, as risk appetite improved after President Trump eased tariff threats against European NATO allies. Senior shares jumped 8.3% on a profit outlook upgrade, while Beazley fell 1% after rejecting a Zurich Insurance bid. JD Sports reported a 1.8% drop in like-for-like sales and warned of muted growth ahead.
Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal founder Deepinder Goyal will step down as CEO on Feb. 1, with Blinkit head Albinder Dhindsa taking over. Dr Reddy’s won approval to sell a generic Ozempic in India and plans to launch 12 million semaglutide pens in the first year. Waaree Energies more than doubled its profit, while HPCL and Bank of India also reported higher earnings for the quarter.
22 January 2026
India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

Australia’s S&P/ASX 200 rose 0.8% to 8,849, snapping a three-day losing streak, as energy and banks advanced but miners fell 1.6%. Santos and South32 each gained about 5%, while Northern Star dropped 8.8% on weak results. The unemployment rate fell to 4.1% and jobs surged by 65,200, lifting rate hike bets. AUSTRAC ordered an external audit of Airwallex over anti-money laundering concerns.
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed shares dropped 3.4% to $11.64 in premarket trading Thursday, following a 94.7% surge the previous session after its Lucid Diagnostics unit secured a U.S. Veterans Affairs contract for the EsoGuard test. Lucid shares fell 10.6% premarket. Investors are seeking details on test rollout and volumes. PAVmed recently completed a 1-for-30 reverse stock split to meet Nasdaq requirements.
Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Indian shares rebounded Thursday, with the Nifty 50 up 0.53% and Sensex gaining 0.49%, after President Trump dropped tariff threats against Europe and Greenland. The rally lost steam as profit-taking and foreign selling weighed, with FIIs net selling ₹1,788 crore. Dr. Reddy’s rose 5.2% on strong earnings, while Eternal fell 2.7% amid quick-commerce sector pressure.
22 January 2026
Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft shares fell 33% after the company announced a major restructuring and canceled six games, cutting its 2026 net bookings forecast to 1.5 billion euros and projecting a 1 billion euro operating loss. The company withdrew guidance for fiscal 2026/27. Trading paused at 4.6 euros per share, valuing Ubisoft at 616 million euros. Investors await further details at a Feb. 12 update.
22 January 2026
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
New York, Feb 7, 2026, 17:36 EST — Market closed. Walt Disney shares rose 3.6% on Friday to close at $108.70, trimming the damage from an early-week slide as U.S. stocks snapped back into risk-on mode. (Yahoo Finance) With U.S. markets shut for the weekend, the next session opens with Disney caught between two big forces: a market that is suddenly willing to buy again, and a media business that is still being rewired in public. For Disney, that matters now because its most visible growth levers — streaming and experiences — move on sentiment as much as on the
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop